Pages that link to "Q46461127"
Jump to navigation
Jump to search
The following pages link to Economic burden prior to COPD diagnosis: a matched case-control study in the United States (Q46461127):
Displaying 25 items.
- Prevalence of airflow obstruction in U.S. adults aged 40-79 years: NHANES data 1988-1994 and 2007-2010 (Q23910517) (← links)
- Health Outcomes Associated with Lung Function Decline and Respiratory Symptoms and Disease in a Community Cohort (Q23919393) (← links)
- Rising Costs of COPD and the Potential for Maintenance Therapy to Slow the Trend (Q27026708) (← links)
- New clinical insights into chronic obstructive pulmonary disease and their implications for pharmacoeconomic analyses (Q30419928) (← links)
- Management of asthma and chronic obstructive pulmonary disease with combination inhaled corticosteroids and long-acting β-agonists: a review of comparative effectiveness research. (Q33646667) (← links)
- Future impact of various interventions on the burden of COPD in Canada: a dynamic population model (Q34447408) (← links)
- Economic burden of chronic bronchitis in the United States: a retrospective case-control study (Q34554777) (← links)
- Value of systematic intervention for chronic obstructive pulmonary disease in a regional Japanese city based on case detection rate and medical cost (Q35928677) (← links)
- A pragmatic cluster randomized controlled trial of early intervention for chronic obstructive pulmonary disease by practice nurse-general practitioner teams: Study Protocol (Q36278452) (← links)
- Undiagnosed Obstructive Lung Disease in the United States. Associated Factors and Long-term Mortality (Q36490128) (← links)
- Diagnosis of COPD and clinical course in patients with unrecognized airflow limitation (Q36789935) (← links)
- Disproportionate utilization of healthcare resources among veterans with COPD: a retrospective analysis of factors associated with COPD healthcare cost (Q36980698) (← links)
- The use of COPD maintenance therapy following spirometry in General Practice (Q37034234) (← links)
- Delivering cost-effective care for COPD in the USA: recent progress and current challenges. (Q38068458) (← links)
- High rates of physician services utilization at least five years before multiple sclerosis diagnosis (Q38069515) (← links)
- Cost-effectiveness of pharmacotherapy for COPD in ambulatory care: a review (Q38099359) (← links)
- Burden of chronic obstructive pulmonary disease: healthcare costs and beyond (Q38308707) (← links)
- Identifying Chronic Obstructive Pulmonary Disease in Primary Care of Urban Underserved Patients: Tools, Applications, and Challenges (Q39944810) (← links)
- Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies (Q41633769) (← links)
- Community pharmacy-based case finding for COPD in urban and rural settings is feasible and effective (Q42731719) (← links)
- Resource Use and Costs up to Two Years Post Diagnosis Among Newly Diagnosed COPD Patients in the UK Primary Care Setting: A Retrospective Cohort Study (Q44362260) (← links)
- Early intervention for chronic obstructive pulmonary disease by practice nurse and GP teams: a cluster randomized trial. (Q47673947) (← links)
- The unmet global burden of COPD. (Q55257340) (← links)
- Direct and Indirect Costs of Chronic Obstructive Pulmonary Disease in Korea (Q57299816) (← links)
- The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden – the Burden of Obstructive Lung Disease (BOLD) study: cross‐sectional population‐based study (Q84300481) (← links)